A carregar...
Antithyroid Drug Treatment in Graves’ Disease
Graves’ disease is associated with thyrotropin (TSH) receptor stimulating antibody, for which there is no therapeutic agent. This disease is currently treated through inhibition of thyroid hormone synthesis or destruction of the thyroid gland. Recurrence after antithyroid drug (ATD) treatment is com...
Na minha lista:
| Publicado no: | Endocrinol Metab (Seoul) |
|---|---|
| Autor principal: | |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Korean Endocrine Society
2021
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8258321/ https://ncbi.nlm.nih.gov/pubmed/34130446 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3803/EnM.2021.1070 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|